Low-dose vitamin k(1) versus short-term withholding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol - A retrospective comparative study
M. Ortin et al., Low-dose vitamin k(1) versus short-term withholding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol - A retrospective comparative study, HAEMOSTASIS, 28(2), 1998, pp. 57-61
Background: No consensus exists about the management of iatrogenically indu
ced excessive hypocoagulability episodes, Objective: To compare the two mos
t common therapeutic approaches in such situations (discontinuation of the
oral anticoagulant vs. low-dose subcutaneous vitamin K-1) when acenocoumaro
l is the normally used anticoagulant. Patients and Methods: The study was r
etrospective and comparative. Patients received antithrombotic therapy usin
g acenocoumarol. Anticoagulant plasmatic activity was assessed through the
international normalized ratio (INR) recorded from December 1994 to Decembe
r 1997 at two medical centers. Results: INR is brought faster to a safe ran
ge in patients treated with low-dose vitamin K-1 (p = 0.01). Their long-ter
m behavior is also more stable and predictable and no resistance to the ora
l anticoagulant was found. Conclusion: Low-dose vitamin K-1 is a safer ther
apeutic option compared to simply withholding the oral anticoagulant. Its b
est scheme of administration, however, has yet to be defined.